{"id":"https://openalex.org/W7115257331","doi":null,"title":"Cost-minimisation analysis of subcutaneous and intravenous administration of trastuzumab in the treatment of HER2-positive breast cancer at Turku University Hospital","display_name":"Cost-minimisation analysis of subcutaneous and intravenous administration of trastuzumab in the treatment of HER2-positive breast cancer at Turku University Hospital","alternate_titles":[],"publication_year":2024,"publication_date":"2024-01-01","ids":{"openalex":"https://openalex.org/W7115257331"},"language":"sv","primary_location":{"id":"pmh:oai:www.doria.fi:10024/189110","doi":null,"is_oa":true,"landing_page_url":"https://www.doria.fi/handle/10024/189110","pdf_url":"https://www.doria.fi/bitstream/10024/189110/2/wickholm_belinda.pdf","source":{"id":"https://openalex.org/S4377196760","display_name":"Doria (University of Helsinki)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I133731052","host_organization_name":"University of Helsinki","host_organization_lineage":["https://openalex.org/I133731052"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Avhandling pro gradu"},"parent_works":[],"lineage":["https://openalex.org/W7115257331"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.doria.fi/bitstream/10024/189110/2/wickholm_belinda.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Wickholm, Belinda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130217899","display_name":"\u00c5bo Akademi University","ror":"https://ror.org/029pk6x14","country_code":"FI","type":"education","lineage":["https://openalex.org/I130217899"]}],"countries":["FI"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Wickholm, Belinda","raw_affiliation_strings":["Fakulteten f\u00f6r naturvetenskaper och teknik, \u00c5bo Akademi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fakulteten f\u00f6r naturvetenskaper och teknik, \u00c5bo Akademi","institution_ids":["https://openalex.org/I130217899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I130217899"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.009800000116229057,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.9879999756813049},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.9769999980926514},{"id":"https://openalex.org/keywords/cost-minimization-analysis","display_name":"cost-minimization analysis","score":0.8059999942779541},{"id":"https://openalex.org/keywords/drug-administration-costs","display_name":"drug administration costs","score":0.5139999985694885},{"id":"https://openalex.org/keywords/pharmaceutical-waste","display_name":"pharmaceutical waste","score":0.3700000047683716},{"id":"https://openalex.org/keywords/drug-loss","display_name":"drug loss","score":0.39800000190734863},{"id":"https://openalex.org/keywords/patient-satisfaction","display_name":"patient satisfaction","score":0.8679999709129333},{"id":"https://openalex.org/keywords/patient-safety","display_name":"patient safety","score":0.3449999988079071}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.833899974822998},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8295000195503235},{"id":"https://openalex.org/C3017595490","wikidata":"https://www.wikidata.org/wiki/Q17006263","display_name":"University hospital","level":2,"score":0.6545000076293945},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.6363999843597412},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5198000073432922},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38449999690055847},{"id":"https://openalex.org/C2992019943","wikidata":"https://www.wikidata.org/wiki/Q16917","display_name":"General hospital","level":2,"score":0.2624000012874603},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.23649999499320984},{"id":"https://openalex.org/C2987828669","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical study","level":2,"score":0.2249000072479248},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.20440000295639038}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:www.doria.fi:10024/189110","doi":null,"is_oa":true,"landing_page_url":"https://www.doria.fi/handle/10024/189110","pdf_url":"https://www.doria.fi/bitstream/10024/189110/2/wickholm_belinda.pdf","source":{"id":"https://openalex.org/S4377196760","display_name":"Doria (University of Helsinki)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I133731052","host_organization_name":"University of Helsinki","host_organization_lineage":["https://openalex.org/I133731052"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Avhandling pro gradu"}],"best_oa_location":{"id":"pmh:oai:www.doria.fi:10024/189110","doi":null,"is_oa":true,"landing_page_url":"https://www.doria.fi/handle/10024/189110","pdf_url":"https://www.doria.fi/bitstream/10024/189110/2/wickholm_belinda.pdf","source":{"id":"https://openalex.org/S4377196760","display_name":"Doria (University of Helsinki)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I133731052","host_organization_name":"University of Helsinki","host_organization_lineage":["https://openalex.org/I133731052"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Avhandling pro gradu"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7115257331.pdf","grobid_xml":"https://content.openalex.org/works/W7115257331.grobid-xml"},"referenced_works_count":58,"referenced_works":["https://openalex.org/W197699128","https://openalex.org/W1549851394","https://openalex.org/W1583886175","https://openalex.org/W1601571585","https://openalex.org/W1648925388","https://openalex.org/W1906683030","https://openalex.org/W1967525869","https://openalex.org/W1976956940","https://openalex.org/W1983651981","https://openalex.org/W1985534261","https://openalex.org/W1992025567","https://openalex.org/W2003536414","https://openalex.org/W2015186160","https://openalex.org/W2034003932","https://openalex.org/W2036752075","https://openalex.org/W2038383229","https://openalex.org/W2055967994","https://openalex.org/W2056839334","https://openalex.org/W2086661954","https://openalex.org/W2093906084","https://openalex.org/W2096012037","https://openalex.org/W2103016616","https://openalex.org/W2103188542","https://openalex.org/W2104186193","https://openalex.org/W2107103026","https://openalex.org/W2123206362","https://openalex.org/W2138977450","https://openalex.org/W2143738177","https://openalex.org/W2155548163","https://openalex.org/W2169782526","https://openalex.org/W2277879584","https://openalex.org/W2281827925","https://openalex.org/W2475799443","https://openalex.org/W2517105328","https://openalex.org/W2621391008","https://openalex.org/W2767743184","https://openalex.org/W2773709250","https://openalex.org/W2786427149","https://openalex.org/W2793063962","https://openalex.org/W2895741523","https://openalex.org/W2914573828","https://openalex.org/W3005440288","https://openalex.org/W3006321831","https://openalex.org/W3097229587","https://openalex.org/W3114719742","https://openalex.org/W3128646645","https://openalex.org/W3130246562","https://openalex.org/W3161359744","https://openalex.org/W3202647386","https://openalex.org/W4211123279","https://openalex.org/W4252714226","https://openalex.org/W4283271486","https://openalex.org/W4294189863","https://openalex.org/W4308967972","https://openalex.org/W4313389567","https://openalex.org/W4352978504","https://openalex.org/W4387799050","https://openalex.org/W4390745681"],"related_works":["https://openalex.org/W2411990866","https://openalex.org/W2771254106","https://openalex.org/W4243676040","https://openalex.org/W2178144403","https://openalex.org/W2255452683","https://openalex.org/W3028053468","https://openalex.org/W2773709250","https://openalex.org/W1988149797","https://openalex.org/W3005440288","https://openalex.org/W2765312235"],"abstract_inverted_index":{"Trastuzumab":[0,14,56],"(Herceptin\uf0d2)":[1],"\u00e4r":[2,65,75,81,122,128,215,226,250,287,303],"en":[3,27,63,72,110,265,274,336],"human":[4],"monoklonal":[5],"antikropp":[6],"som":[7,127,155,162,174,203,283],"anv\u00e4nds":[8],"vid":[9,83,105,292,297,308,313,350,361],"behandling":[10,95,258],"av":[11,87,157,285],"HER2-positiv":[12],"br\u00f6stcancer.":[13],"kan":[15,333,344],"administreras":[16,57,334],"b\u00e5de":[17,195,360],"intraven\u00f6st":[18],"(iv)":[19],"och":[20,30,107,109,168,182,191,197,220,278,294,310,331,363,377],"subkutant":[21],"(sc),":[22],"d\u00e4r":[23,60,209],"respektive":[24,140],"behandlingsalternativ":[25,132],"har":[26],"likv\u00e4rdig":[28],"effektivitets-":[29],"s\u00e4kerhetsprofil.":[31],"Vid":[32,45,352],"iv-behandling":[33,353],"tillverkas":[34,329],"dosen":[35],"patientspecifikt":[36,330],"i":[37,89,143,192,264,288,304,318],"\u00c5bo":[38],"universitetscentralsjukhus":[39],"(\u00c5UCS)":[40],"cytostatikalaboratorium":[41],"enligt":[42],"patientens":[43,183],"vikt.":[44,55],"sc-behandling":[46,293,309],"erh\u00e5ller":[47],"alla":[48,137,153],"patienter":[49],"samma":[50],"dosstyrka":[51],"(600":[52],"mg),":[53],"oavsett":[54],"p\u00e5":[58,85,374],"cancerpolikliniken,":[59],"administreringstiden":[61],"f\u00f6r":[62,71,115,145,164,171,179,218,223,242,270,357],"infusion":[64],"ca":[66],"30":[67],"minuter,":[68],"medan":[69],"tiden":[70],"subkutan":[73],"injektion":[74],"2-5":[76],"minuter.":[77],"Behandling":[78],"med":[79,96,99,118,248,254,325,372],"iv-trastuzumab":[80,97,219,328],"dominerande":[82],"\u00c5UCS":[84,134,239],"grund":[86],"skillnaden":[88],"grossistpris":[90],"mellan":[91,212],"l\u00e4kemedlena,":[92],"trots":[93],"att":[94,123,151],"f\u00f6rknippas":[98],"\u00f6kade":[100,259],"resurser":[101,260],"fr\u00e5n":[102,261],"h\u00e4lsov\u00e5rdspersonal,":[103,158],"till\u00e4ggskostnader":[104],"beredning":[106,362],"administrering":[108],"\u00f6kad":[111,266,275],"s\u00e4ng-":[112,184,267,300],"eller":[113,185,268,301],"stolstid":[114,269,302],"patienten.":[116],"M\u00e5ls\u00e4ttningen":[117],"denna":[119],"pro":[120],"gradu":[121],"unders\u00f6ka":[124],"vilken":[125],"administreringsform":[126],"ett":[129,207,228,368],"mer":[130,229,322,369],"kostnadseffektivt":[131,230],"ur":[133,238],"perspektiv,":[135],"d\u00e5":[136,234],"kostnader":[138,170,178,237],"kring":[139],"administreringssform":[141],"tas":[142],"beaktande":[144],"\u00e5r":[146,243],"2022.":[147,244],"Kostnaderna":[148],"ber\u00e4knas":[149,241],"genom":[150],"kartl\u00e4gga":[152,167],"arbetsskeden":[154],"utf\u00f6rs":[156],"m\u00e4ta":[159],"den":[160,340],"arbetstid":[161,282],"kr\u00e4vs":[163,284],"varje":[165],"arbetsskede,":[166],"ber\u00e4kna":[169,177],"det":[172],"material":[173],"anv\u00e4nds,":[175],"samt":[176,272],"l\u00e4kemedelsavfall,":[180],"l\u00e4kemedelssvinn":[181,277,348],"stolstid.":[186],"Som":[187],"metod":[188],"till\u00e4mpas":[189,194],"kostnadsminimeringsanalys,":[190],"studien":[193],"kvantitativa":[196],"kvalitativa":[198],"forskningsmetoder.":[199],"De":[200],"totala":[201],"kostnaderna":[202],"h\u00e4nf\u00f6r":[204],"sig":[205],"till":[206],"behandlingstillf\u00e4lle,":[208],"enbart":[210,349],"skillnader":[211],"administreringsalternativen":[213],"beaktats,":[214],"304,91":[216],"\u20ac":[217,222],"850,64":[221],"sc-trastuzumab.":[224],"Iv-administrering":[225],"d\u00e4rmed":[227],"alternativ":[231,371],"\u00e4n":[232,253],"sc-administrering":[233],"direkta":[235],"medicinska":[236],"perspektiv":[240],"\u00c4ven":[245],"om":[246],"behandlingskostnaderna":[247],"sc-trastuzumab":[249,367],"avsev\u00e4rt":[251],"h\u00f6gre":[252],"iv-trastuzumab,":[255],"kr\u00e4ver":[256],"intraven\u00f6s":[257],"h\u00e4lsov\u00e5rdpersonal,":[262],"resulterar":[263,316],"patienten,":[271],"genererar":[273],"m\u00e4ngd":[276],"l\u00e4kemedelsavfall.":[279],"Den":[280],"aktiva":[281],"h\u00e4lsov\u00e5rdspersonal":[286],"medeltal":[289,305],"11":[290,306],"minuter":[291,296,307,312],"29":[295],"iv-behandling.":[298,314,351],"Patientens":[299],"58":[311],"Iv-behandling":[315],"\u00e4ven":[317,355],"n\u00e4stan":[319],"sex":[320],"g\u00e5nger":[321],"l\u00e4kemedelsavfall":[323],"j\u00e4mf\u00f6rt":[324],"sc-behandling.":[326],"Eftersom":[327],"inte":[332,343],"\u00e5t":[335],"annan":[337],"patient":[338],"ifall":[339],"ursprungliga":[341],"patienten":[342],"f\u00e5":[345],"dosen,":[346],"f\u00f6rekommer":[347],"\u00f6kar":[354],"risken":[356],"m\u00e4nskliga":[358],"fel,":[359],"administrering.":[364],"D\u00e4rmed":[365],"vore":[366],"f\u00f6rdelaktigt":[370],"tanke":[373],"patients\u00e4kerhet,":[375],"milj\u00f6n":[376],"effektiv":[378],"resursanv\u00e4ndning.":[379]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7115257331","counts_by_year":[],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2025-12-15T00:00:00"}
